Page last updated: 2024-10-25

diazepam and Immunologic Deficiency Syndromes

diazepam has been researched along with Immunologic Deficiency Syndromes in 1 studies

Diazepam: A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity.
diazepam : A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one substituted by a chloro group at position 7, a methyl group at position 1 and a phenyl group at position 5.

Immunologic Deficiency Syndromes: Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Galdiero, F1
Bentivoglio, C1
Nuzzo, I1
Ianniello, R1
Capasso, C1
Mattera, S1
Nazzaro, C1
Galdiero, M1
Romano Carratelli, C1

Other Studies

1 other study available for diazepam and Immunologic Deficiency Syndromes

ArticleYear
Effects of benzodiazepines on immunodeficiency and resistance in mice.
    Life sciences, 1995, Nov-17, Volume: 57, Issue:26

    Topics: Animals; Anti-Anxiety Agents; Antibody Formation; B-Lymphocytes; Bacteremia; Benzodiazepines; Cell A

1995